Study to Assess the Efficacy and Safety of PT003 in Subjects with Moderate to Severe COPD

Trial Identifier: PT003013
Sponsor: Pearl Therapeutics, Inc.
NCTID:: NCT02454959
Start Date: May 2015
Primary Completion Date: March 2016
Study Completion Date: March 2016
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, FL Clearwater, FL, US
US, FL Tampa, FL, US
US, NC Charlotte, NC, US
US, NC Winston-Salem, NC, US
US, SC Gaffney, SC, US
USA, FL Winter Park, FL, USA